November 5, 2026

Neng Nana

The Frontlines of MBC Advocacy: METAvivor Navigates Fiscal Uncertainty and Legislative Hurdles in March Update the-frontlines-of-mbc-advocacy-metavivor-navigates-fiscal-uncertainty-and-legislative-hurdles-in-march-update

The Frontlines of MBC Advocacy: METAvivor Navigates Fiscal Uncertainty and Legislative Hurdles in March Update

Neng Nana July 12, 2026
WASHINGTON, D.C. — As the first quarter of the year concludes, the metastatic breast cancer (MBC) advocacy...
Read More Read more about The Frontlines of MBC Advocacy: METAvivor Navigates Fiscal Uncertainty and Legislative Hurdles in March Update
Dr. C. Bob Basu Ascends to Presidency of the American Society of Plastic Surgeons: A New Era of Innovation and Safety dr-c-bob-basu-ascends-to-presidency-of-the-american-society-of-plastic-surgeons-a-new-era-of-innovation-and-safety

Dr. C. Bob Basu Ascends to Presidency of the American Society of Plastic Surgeons: A New Era of Innovation and Safety

Neng Nana July 9, 2026
NEW ORLEANS — In a pivotal moment for the global aesthetic and reconstructive surgery community, the American...
Read More Read more about Dr. C. Bob Basu Ascends to Presidency of the American Society of Plastic Surgeons: A New Era of Innovation and Safety

You may have missed

t-therapeutics-secures-133-million-series-b-to-propel-undruggable-t-cell-engager-pipeline

T-Therapeutics Secures $133 Million Series B to Propel “Undruggable” T-Cell Engager Pipeline

Asro November 5, 2026
the-precision-revolution-merck-and-modernas-personalized-cancer-vaccine-poised-to-reshape-oncology

The Precision Revolution: Merck and Moderna’s Personalized Cancer Vaccine Poised to Reshape Oncology

Sagoh November 5, 2026
breakthrough-in-breast-cancer-penn-scientists-uncover-path-to-eradicate-dormant-cells-prevent-recurrence

Breakthrough in Breast Cancer: Penn Scientists Uncover Path to Eradicate Dormant Cells, Prevent Recurrence

Siti Muinah November 5, 2026
mhra-embraces-contextual-safety-assessments-for-clinical-trial-applications-bolstering-uks-regulatory-agility

MHRA Embraces Contextual Safety Assessments for Clinical Trial Applications, Bolstering UK’s Regulatory Agility

Azzam Bilal Chamdy November 5, 2026